Myeloma: Daratumumab Plus Lenalidomide Improves MRD Outcomes ...Middle East

Medscape - News
Adding daratumumab to lenalidomide in maintenance therapy for multiple myeloma significantly reduced rates of minimal residual disease. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Myeloma: Daratumumab Plus Lenalidomide Improves MRD Outcomes )

Apple Storegoogle play

Also on site :